Previous Article | Next Article ![]()
Journal of Bacteriology, December 2005, p. 8196-8200, Vol. 187, No. 23
0021-9193/05/$08.00+0 doi:10.1128/JB.187.23.8196-8200.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Qin Sheng,1
Jonathan R. McClain,1
Anna Riley,1
Pei-Ming Sun,1
Wai-Leung Ng,2
Dalai Yan,1,
Thalia I. Nicas,1
Kenneth Henry,1 and
Malcolm E. Winkler2*
Eli Lilly and Company, Indianapolis, Indiana 46285,1 Department of Biology, Indiana University, Bloomington, Indiana 474052
Received 13 July 2005/ Accepted 8 September 2005
Bacterial histidine kinases have been proposed as targets for the discovery of new antibiotics, yet few specific inhibitors of bacterial histidine kinases have been reported. We report here a novel thienopyridine (TEP) compound that inhibits bacterial histidine kinases competitively with respect to ATP but does not comparably inhibit mammalian serine/threonine kinases. Although it partitions into membranes and does not inhibit the growth of bacterial or mammalian cells, TEP could serve as a starting compound for a new class of histidine kinase inhibitors with antibacterial activity.
Present address: Protana, Inc., 251 Attwell Dr., Toronto, ON, Canada M9W 7H4.
Present address: Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202.
This article has been cited by other articles:
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |